Colorectal Cancer Therapeutics Market in APAC 2015-2019

Published: Dec 2015 Pages: 94 SKU: IRTNTR7888

Market outlook of the colorectal cancer therapeutics market in the APAC region

Colorectal cancer is a type of cancer that affects colon or rectum. The risk factors identified for this cancer include age, family history, unhealthy lifestyle, genetic disorders, and inflammatory bowel disease. Different types of therapy such as chemotherapy, surgical, biologic, and radiation therapy are being developed and administered to the colorectal patients to alleviate this disease.

Technavio’s analysts expect the colorectal cancer therapeutics market in the APAC region to grow at a moderate rate, posting a CAGR of more than 6% during the forecast period.

The presence of high unmet medical need is one of the major drivers propelling the growth of the market. Colorectal cancers cannot be cured completely by the currently available therapies and if it has not metastasized, surgery would be the only treatment option. As a result, a drug manufacturer has immense opportunities to exploit and seek a favorable position in the market by developing appropriate drugs and mitigate this issue.

End-user segmentation of the colorectal cancer therapeutics market in APAC

  • Small molecules
  • Biologics

The small molecules segment includes chemical entities characterized by low molecular weight and a less complex structure as compared to biologics. They are easy to manufacture through chemical synthesis, more stable than biologics, and mostly non-immunogenic.

Segmentation of the colorectal cancer therapeutics market in APAC by lines of chemotherapy

  • First-line chemotherapy
  • Second-line chemotherapy

First-line chemotherapy therapy is the treatment regimen or regimens that are generally accepted by the medical establishment for primary treatment and stage of cancer. First-line therapy is also called as a standard therapy.

Competitive landscape and key vendors

The colorectal cancer therapeutics market in the APAC region is witnessing moderate growth because of a rise in the prevalence of colorectal cancer and unmet medical needs. Therefore, companies that manufacture and market drugs that can treat colorectal cancer effectively and cure, besides exhibiting a high safety and efficacy profile, are expected to gain a competitive edge over other companies in this market.

Key vendors in this market are -

  • Amgen
  • Bayer Healthcare
  • Bristol-Myers Squibb
  • Chugai Pharmaceutical
  • Merck
  • Sanofi

Other prominent vendors included in this report are Accord Healthcare, Advenchen Laboratories, Aeterna Zentaris, AstraZeneca, AVEO Oncology, Bavarian Nordic, Biothera, Boehringer Ingelheim, Boston Biomedical, Celator Pharmaceuticals, Cancer Prevention Pharmaceuticals, Daiichi Sankyo, Debiopharm, Eisai, Eli Lilly, EpicentRx, GlaxoSmithKline, Hutchison Medipharma, Immodulon Therapeutics, Immunomedics, MacroGenics, Merrimack Pharmaceuticals, Morphotek, Mologen, MolMed, Mylan, Nektar Therapeutics, Oncothyreon, Otsuka Pharmaceutical, Precision Biologics, PsiOxus Therapeutics, PledPharma, Sun Pharmaceutical, Symphogen, Taiho, Takeda, Teva, ThromboGenics, Xbiotech, and Yakult Honsha.

Key questions answered in the report include

  • What will the market size and the growth rate be in 2019?
  • What are the key factors driving the colorectal cancer therapeutics market in APAC?
  • What are the key market trends impacting the growth of the colorectal cancer therapeutics market in APAC?
  • What are the challenges to market growth?
  • Who are the key vendors in the colorectal cancer therapeutics market in APAC?
  • What are the market opportunities and threats faced by the vendors in the colorectal cancer therapeutics market in APAC?
  • What are the key outcomes of the five forces analysis of the colorectal cancer therapeutics market in APAC?

Technavio also offers customization on reports based on specific client requirement.

Related reports

Table of Contents

PART 01:  Executive summary

  • Highlights

PART 02:  Scope of  the report

  • Market overview
  • Top-vendor offerings
  • Vectibix

PART 03:  Product profiles

  • Stivarga
  • Erbitux
  • Xeloda
  • Avastin
  • Zaltrap

PART 04:  Market research methodology

  • Research methodology
  • Economic indicators

PART 05:  Introduction

  • Key market highlights

PART 06:  Disease overview

  • Understanding the disease
  • High risk factors
  • Signs and symptoms
  • Pathophysiology
  • Diagnosis
  • Staging
  • Biomarker testing
  • Epidemiology
  • Treatment

PART 07:  Pipeline portfolio

  • Information on pipeline candidates

PART 08:  Market landscape

  • Market overview
  • Market size and forecast
  • Colorectal cancer therapeutics market in Japan
  • Colorectal cancer therapeutics market in China
  • Five forces analysis

PART 09:  Market segmentation by based on the type of molecules

  • Small molecules
  • Biologics

PART 10:  Market segmentation by route of administration

  • Oral
  • Parenteral

PART 11:  Market segmentation by lines of chemotherapy

  • First-line chemotherapy
  • Second-line chemotherapy

PART 12:  Market drivers

PART 13:  Impact of drivers

PART 14:  Market challenges

PART 15:  Impact of drivers and challenges

PART 16:  Market trends

PART 17:  Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors
  • Amgen

PART 18:  Key vendor analysis

  • Bayer HealthCare
  • Bristol-Myers Squibb
  • Chugai Pharmaceutical
  • Merck
  • Sanofi

PART 19:  Appendix

  • List of abbreviations

PART 20:  Explore Technavio

 

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases

DATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts

REPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape

PURCHASE FULL REPORT OF

market

QUICK BUY

Key Questions Answered

  • What are the key global market and the regional market share?
  • What are the revenue-generating key market segments?
  • What are the key factors driving and challenging this market’s growth?
  • Who are the key market vendors and their growth strategies?
  • What are the latest trends influencing the growth of this market?
  • What are the variables influencing the market growth in the primary regions?
  • What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

  • Off-the-shelf research reports
  • Reports can be tailored to meet the customer's needs
  • Trusted by more than 100 fortune 500 organizations
  • Information about the market's key drivers, trends, and challenges
  • Parent market analysis
  • Every week, 50,000 people visit our subscription platform
  • Detailed vendors report with competitive landscape
  • Covid-19 impact and recovery analysis
  • Data on revenue-generating market segments
  • Details on the market shares of various regions
  • Five-force market analysis